Novo Nordisk says obesity pill leads to 15% weight loss; availability ‘to be determined’

By Deena Beasley SAN DIEGO (Reuters) – Novo Nordisk on Sunday said a late-stage trial found that a high-dose oral version of its drug semaglutide helped overweight or obese adults lose 15% of their body weight, which is in line with recent results for other experimental obesity pills. Novo plans to seek U.S. and European…

Read More

Special Report-US, Swedish prosecutors study graft complaint naming son of Turkey’s Erdogan

By David Gauthier-Villars (Reuters) – Anti-corruption authorities in the United States and Sweden are reviewing a complaint alleging that the Swedish affiliate of a U.S. company pledged to pay tens of millions of dollars in kickbacks if a son of Turkey’s President Recep Tayyip Erdogan helped it secure a dominant market position in the country….

Read More